CD8A and neoplasm: Whereas splenic MDSC immunosuppressed the antigen-specific function of CD8+ T, MDSCs in the TME inhibited tumor-infiltrating lymphocytes (TILs) antigen-specific MHC-I-restricted and general CD3/CD28 triggered activation.